IINBRAIN Neuroelectronics
INBRAIN Neuroelectronics is a Barcelona-based clinical-stage neurotech company developing graphene-based, AI-powered brain-computer interface (BCI) therapeutics to decode and modulate neural activity for treating neurological disorders such as Parkinson's disease and brain tumors. Spun off from ICN2 in 2019, it holds FDA Breakthrough Device Designation and performed the world's first human graphene BCI procedure in 2024. It has raised over $80M to date, most recently a $50M Series B led by imec.xpand, and has a strategic partnership with Merck KGaA.
SectorsBrain-computer interfaces, Neurotech, Medical devices, Bioelectronics, Graphene/nanomaterials
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
A
Anton Guimerà Brunet
Co-founder & Technology Advisor
C
Carolina Aguilar
CEO & Co-founder
J
Jose Antonio Garrido
Co-founder & Chief Scientific Officer
K
Kostas Kostarelos
Co-founder
M
Mario Capizzani
Co-founder & Chief Commercial Officer
Global models 5
NNeuralink
United States · neuralink.com ↗
Direct global comparable building implantable brain-computer interfaces to decode and modulate neural activity, though focused more on motor/communication restoration than INBRAIN's neurological disease therapeutics.
$1.3BComparable
SSynchron
United States · synchron.com ↗
Develops minimally-invasive BCI implants (Stentrode) to decode neural signals for paralysis patients, closely matching INBRAIN's neural-decoding therapeutic BCI model.
$255MComparable
PPrecision Neuroscience
United States · precisionneuro.io ↗
Builds high-resolution, minimally invasive cortical neural interfaces for brain mapping and BCI applications, similar to INBRAIN's high-resolution graphene electrode approach.
$155MComparable
PParadromics
United States · www.paradromics.com ↗
Develops high-bandwidth implantable neural interfaces for decoding brain activity to treat neurological conditions, a close model match to INBRAIN's BCI-therapeutics platform.
$150MComparable
BBlackrock Neurotech
United States · blackrockneuro.com ↗
Long-standing developer of implantable brain-computer interface hardware for neural decoding and neuromodulation therapies, mirroring INBRAIN's clinical BCI focus.
$90MComparable
In the same niche 72 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 18
Open as list →
AAsabys Partners
asabys.com
AAlta Life Sciences
altals.com
A
Avançsa
avancsa.gencat.cat
EEuropean Investment Bank
www.eib.org
SSabadell Venture Capital
www.bancsabadell.com
CCentro para el Desarrollo Tecnológico y la Innovación
www.cdti.es
A
AXIS
axispart.com
EEIC Fund
eic.ec.europa.eu
F
Finaves
iese.edu/entrepreneurship/finaves
I
Institut Català de Finances
icf.cat
Iimec.xpand
VVsquared Ventures
AAliath Bioventures
IICN2
T
TruVenturo
E
Earthshots Collective
KKarista
WWellington Partners
Funding rounds 6
·1 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-11-26 | Series B (estimated) | €3M | Avançsa |
| 2024-10-29 | Series B | $50M |
imec.xpand
+7 more
|
| 2023-12-13 | Venture Debt | €20M | European Investment Bank |
| 2021-03-30 | Series A | €14.4M |
Asabys Partners, Alta Life Sciences
+3 more
|
| 2020-11-03 | Seed | €100K | BStartup (Banco Sabadell) |
| 2020-06-11 | Seed | approximately €1M |
Asabys Partners, Alta Life Sciences
+3 more
|